Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer

被引:38
作者
Wu, Bo [1 ,2 ]
Chu, Xiaoyu [1 ,2 ]
Feng, Cong [1 ,2 ]
Hou, Junwei [2 ]
Fan, Hongxia [2 ]
Liu, Ningning [2 ]
Li, Changfei [2 ]
Kong, Xianping [3 ]
Ye, Xin [2 ]
Meng, Songdong [2 ]
机构
[1] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China
[2] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China
[3] 458th Hosp, Ctr Infect Dis, Transgen Engn Res Lab, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
gp96; Apoptosis; Ubiquitination; Chaperone; TOLL-LIKE RECEPTORS; HEPATOCELLULAR-CARCINOMA; CHAPERONE GP96; THERAPEUTIC-TARGET; MACROPHAGES; METASTASIS; GP96/GRP94; EXPRESSION; ONCOGENE; PATHWAY;
D O I
10.1016/j.canlet.2015.01.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The resistance to apoptosis displayed by liver cancer plays a key role in hepatocarcinogenesis, tumor progression, and resistance to chemo- or radio-therapy. In this study, we uncovered the potential role and mechanism of heat shock protein gp96 in regulating liver tumor cell growth and apoptosis. P53 protein was identified as a gp96 client protein by profiling apoptosis-related proteins in gp96-knockdown liver cancer cells. Overexpression and knockdown studies both demonstrated that gp96 decreases p53 protein levels, and gp96 regulated cell apoptosis in a p53-dependent manner. We further provide evidence that gp96 interacts with both p53 and Mdm2 to enhance Mdm2-mediated p53 ubiquitination and degradation. Moreover, targeting gp96 with siRNA induced cell apoptosis and led to the suppression of liver tumor growth in vivo. In conclusion, we elucidated an underlying mechanism by which gp96 promotes p53 degradation via increasing Mdm2 E3 ligase activity and provided a new therapeutic strategy to target the gp96-mediated anti-apoptotic characteristic of hepatocellular carcinoma. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:325 / 334
页数:10
相关论文
共 32 条
[1]  
Bursac S., 2014, BIOCHIM BIOPHYS ACTA, P817
[2]   Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15 [J].
Chang, Joseph Tung-Chieh ;
Chan, Shih-Hsuan ;
Lin, Chien-Yu ;
Lin, Ting-Yang ;
Wang, Hung-Ming ;
Liao, Chun-Ta ;
Wang, Tzu-Hao ;
Lee, Li-Yu ;
Cheng, Ann-Joy .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) :2271-2279
[3]   ATM activates p53 by regulating MDM2 oligomerization and E3 processivity [J].
Cheng, Qian ;
Chen, Lihong ;
Li, Zhenyu ;
Lane, William S. ;
Chen, Jiandong .
EMBO JOURNAL, 2009, 28 (24) :3857-3867
[4]   Reversing hepatocellular carcinoma progression by using networked biological therapies [J].
Epstein, Richard J. ;
Leung, Thomas W. .
CLINICAL CANCER RESEARCH, 2007, 13 (01) :11-17
[5]   Increased Expression of Gp96 by HBx-Induced NF-κB Activation Feedback Enhances Hepatitis B Virus Production [J].
Fan, Hongxia ;
Yan, Xiaoli ;
Zhang, Yu ;
Zhang, Xiaojun ;
Gao, Yanzhou ;
Xu, Yaxing ;
Wang, Fusheng ;
Meng, Songdong .
PLOS ONE, 2013, 8 (06)
[6]   Mdm2's Dilemma: To Degrade or To Translate p53? [J].
Hamard, Pierre-Jacques ;
Manfredi, James J. .
CANCER CELL, 2012, 21 (01) :3-5
[7]   α7 Helix Region of αI Domain Is Crucial for Integrin Binding to Endoplasmic Reticulum Chaperone gp96 A POTENTIAL THERAPEUTIC TARGET FOR CANCER METASTASIS [J].
Hong, Feng ;
Liu, Bei ;
Chiosis, Gabriela ;
Gewirth, Daniel T. ;
Li, Zihai .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (25) :18243-18248
[8]   Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma [J].
Hua, Yunpeng ;
White-Gilbertson, Shai ;
Kellner, Joshua ;
Rachidi, Saleh ;
Usmani, Saad Z. ;
Chiosis, Gabriela ;
DePinho, Ronald ;
Li, Zihai ;
Liu, Bei .
CLINICAL CANCER RESEARCH, 2013, 19 (22) :6242-6251
[9]   TP53 mutations and hepatocellular carcinoma:: insights into the etiology and pathogenesis of liver cancer [J].
Hussain, S. P. ;
Schwank, J. ;
Staib, F. ;
Wang, X. W. ;
Harris, C. C. .
ONCOGENE, 2007, 26 (15) :2166-2176
[10]   Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus [J].
Langer, Rupert ;
Feith, Marcus ;
Siewert, Joerg Ruediger ;
Wester, Hans-Juergen ;
Hoefler, Heinz .
BMC CANCER, 2008, 8 (1)